These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 8224569)

  • 1. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis.
    Lankisch PG
    Digestion; 1993; 54 Suppl 2():21-9. PubMed ID: 8224569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
    Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
    Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic enzyme therapy.
    Mössner J; Keim V
    Dtsch Arztebl Int; 2010 Aug; 108(34-35):578-82. PubMed ID: 21904592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin].
    Aparisi L; Rodrigo JM; Serra MA; Del Olmo J; Bisquert M; Raga F
    Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):25-30. PubMed ID: 2799034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
    Pap A; Varró V
    Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?
    Domínguez-Muñoz JE
    Adv Med Sci; 2011; 56(1):1-5. PubMed ID: 21450558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults.
    Opekun AR; Sutton FM; Graham DY
    Aliment Pharmacol Ther; 1997 Oct; 11(5):981-6. PubMed ID: 9354210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea.
    Lembcke B; Grimm K; Lankisch PG
    Am J Gastroenterol; 1987 Jun; 82(6):526-31. PubMed ID: 3646827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Requirements for successful pancreatic enzyme replacement therapy (comparative study of Kreon and Panpur)].
    Pap A; Korom M; Marosi E; Varró V
    Orv Hetil; 1990 Feb; 131(5):241-4. PubMed ID: 2304764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.
    DiMagno EP; Malagelada JR; Go VL; Moertel CG
    N Engl J Med; 1977 Jun; 296(23):1318-22. PubMed ID: 16213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme substitution in pancreatic disease.
    Andrén-Sandberg A
    Digestion; 1987; 37 Suppl 1():35-46. PubMed ID: 3650182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J; Lerner S; Meyer JH
    Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New methods for assessment of enzyme activity: do they help to optimize enzyme treatment?
    Adler G; Mundlos S; Kühnelt P; Dreyer E
    Digestion; 1993; 54 Suppl 2():3-9. PubMed ID: 7693531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of pancreatic enzymes in the human intestinal lumen in health and pancreatic insufficiency.
    Layer P; Gröger G
    Digestion; 1993; 54 Suppl 2():10-4. PubMed ID: 7693530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequate enzymatic substitution in treating exocrine pancreatic insufficiency.
    Simek I; Kubias K; Duda M
    Acta Physiol Hung; 1992; 80(1-4):417-21. PubMed ID: 1364280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.